Cellectar Biosciences, Inc.
CLRB
$0.2515
$0.00732.99%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 143.48% | 80.46% | 402.02% | 215.64% | -51.85% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.28% | 45.60% | 345.92% | 14.91% | 33.93% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 131.99% | 78.52% | 397.45% | 198.77% | -49.08% |
|
|
|||||
| Total Current Assets | 131.99% | 78.52% | 397.45% | 198.77% | -49.08% |
| Net Property, Plant & Equipment | -25.03% | -3.32% | 66.67% | 63.70% | 62.68% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | -57.06% | -63.30% |
| Total Assets | 110.95% | 73.05% | 351.43% | 189.17% | -44.07% |
|
|
|||||
| Total Accounts Payable | -55.27% | 6.27% | 1.12% | 7.09% | 258.76% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 43.05% | 43.52% | 44.22% | 44.81% | 16.14% |
| Total Finance Division Other Current Liabilities | -89.34% | 38.71% | -- | -- | 169.57% |
| Total Other Current Liabilities | -89.34% | 38.71% | -- | -- | 169.57% |
| Total Current Liabilities | -62.98% | 23.34% | 135.34% | 310.47% | 120.48% |
|
|
|||||
| Total Current Liabilities | -62.98% | 23.34% | 135.34% | 310.47% | 120.48% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.09% | -15.78% | -14.58% | -13.50% | -10.67% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -62.10% | 22.15% | 123.93% | 286.80% | 114.46% |
|
|
|||||
| Common Stock & APIC | 42.75% | 26.24% | 20.78% | 15.88% | 8.79% |
| Retained Earnings | -21.99% | -16.64% | -17.33% | -21.97% | -26.73% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 169.44% | 110.52% | 345.40% | -176.72% | -343.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -68.60% | -22.30% | 567.55% | 1,235.00% | 338.47% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -68.60% | -22.30% | 567.55% | 1,235.00% | 338.47% |
|
|
|||||
| Total Common Equity | 169.44% | 110.52% | 345.40% | -176.72% | -343.30% |
| Total Preferred Equity | -68.60% | -22.30% | 567.55% | 1,235.00% | 338.47% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 213.79% | 262.30% | 3,047.11% | 89.28% | -244.48% |
|
|
|||||